The AmnioBed is a novel incubator system for neonatal intensive care units incorporating synthetic amniotic fluid in a self-regulating, sterile, submersion bath, providing an environment similar to what infants resided in before birth
NEWPORT BEACH, Calif., Nov. 12, 2018 /PRNewswire/ -- The pressing need to address growing premature births in the world inspired Amnion Life, (https://amnion.life/), to develop the AmnioBed, an amniotic, neonatal incubator system that incorporates unparalleled technology to promote ongoing development immediately following birth. This patented, cost-efficient, incubation device features an amniotic fluid submersion bath that simulates the mother’s womb, providing a potentially ideal environment to nurture infants at their most vulnerable stage of life. Amnion Life Founder and CEO, Amir Fassihi, M.D., is confident that the AmnioBed will prove to be advantageous over radiant warmer beds and convection warmed incubators in offering improved thermoregulation, hydration, and skin protection, helping to reduce complications and save lives, while also reducing costs. “The AmnioBed has the potential to reduce the length of stay (LOS) for infants and to improve the rate of weight gain and growth in the NICU, thus saving significant direct costs of short and long-term visits, in addition to providing infants with improved health and comfort,” Fassihi said. Notable features of the AmnioBed include:
Amnion Life has launched an awareness and equity campaign for the AmnioBed, (https://wefunder.com/amnionlife), to share the potential of this promising product. ABOUT AMNION LIFE Established in 2016, Amnion Life is a medical company in pursuit of innovative medical devices for preterm infants. Media Contact: View original content to download multimedia:http://www.prnewswire.com/news-releases/patented-innovative-infant-incubator-system-for-potentially-faster-less-expensive-yet-healthier-care-for-those-most-vulnerable-300747888.html SOURCE Amnion Life |